INR:9057. marathonbet et Bristol-Myers Squibb's deucravacitinib significantly improves signs and symptoms of psoriatic arthritis Opdivo + Cabometyx combination for ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...
Long-term treatment with guselkumab is associated with sustained improvements in joint/skin symptoms and disease activity among patients with active PsA.